Hematopoietic cell transplantation-comor
β
Mohamed Sorror; Barry Storer; Brenda M. Sandmaier; David G. Maloney; Thomas R. C
π
Article
π
2008
π
John Wiley and Sons
π
English
β 207 KB
## Abstract ## BACKGROUND Elderly and medically infirm cancer patients are increasingly offered allogeneic nonmyeloablative hematopoietic cell transplantation (HCT). A better understanding of the impact of health status on HCT outcomes is warranted. Herein, a recently developed HCTβspecific comorb